We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sarossa | LSE:SARS | London | Ordinary Share | JE00BKWBZV64 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.52 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/7/2020 12:41 | when sellers finished will another bounce come or are some afraid of speeding ticket | bunz3 | |
22/7/2020 12:40 | still more selling | bunz3 | |
22/7/2020 12:31 | lot of selling now ,many sellers now look to be taking profits | bunz3 | |
09/6/2020 13:03 | source : Dow Jones News Danaher Unit Unveils Sars-CoV-2/Flu A/Flu B/RSV Combo Test Alert By Colin Kellaher Danaher Corp.'s Cepheid unit on Tuesday said it has developed a four-in-one test to detect Sars-CoV-2, Flu A, Flu B and respiratory syncytial virus from a single patient sample. The Sunnyvale, Calif., molecular-diagnostic Cepheid said the test will aid global efforts in the fight against Covid-19 during the upcoming respiratory virus season, as all four infections have similar patient presentations but different treatment and management pathways, making accurate detection and differentiation critical. Cepheid said it will pursue U.S. Food and Drug Administration approval of the test under the agency's emergency use authorization pathway. Write to Colin Kellaher at colin.kellaher@wsj.c (END) Dow Jones Newswires June 09, 2020 07:41 ET (11:41 GMT) | waldron | |
17/4/2020 16:05 | even now to watch number of buyers moving back into ncyt after shsre price drop some exspecting rns soon | bunz3 | |
31/8/2016 20:00 | Excuse my ignorance here but if we do not take the Tender Offer, what happens to our shareholding? Do we lose all or will they be converted into something else? | lobby lud | |
01/7/2016 12:46 | Have received circular re proposed acquisition of Ora Limited from (mainly) Richard Griffiths, Rule 9 waiver, tender offer buyback at 1.31p. Ora Limited is valued at £6.1m (full net asset value) Acquisition to be paid for by issuing Sarossa shares at 1.31p. This is half net asset value!! I think this is very poor price for independent shareholders. I will vote against. | charlie | |
08/1/2016 11:48 | PHC are down from 115 to 84 since June results and SLN are down from 305 to 150 Means the P+L will be taking a very big hit and the buyback programme of 90m at 1.72p looks a bit foolish with hindsight...with the delisting to come this is looking a bit rough. DYOR GLA | hlp_4u | |
08/1/2016 11:36 | Now 41.617 million have scudded through at 1.31 | hlp_4u | |
07/1/2016 15:48 | A sale of 34.25 million at 1.31p is a vote of confidence NOT....with it soon to be delisted this is heading fast to sub 1p | hlp_4u | |
11/12/2015 13:15 | Griffiths screwed the shareholders just like with ORA capital. I guess he is doing it so that he can buy back most of the shares at a heavily discounted rate. He will make a fortune on his holding, everyone else gets screwed :( In future, I would not recommend buying any small holding where Griffiths is the majority shareholder. He seems to have a habit of screwing small shareholders. | johnsmith321 | |
01/12/2015 13:38 | No tender offer at NAV like with Jim Mellon and plethora. | johnsmith321 | |
01/12/2015 09:35 | PHC down another big chunk despite henderson topping up | hlp_4u | |
19/11/2015 11:44 | Hi Hlp_4U, I agree with you a revaluation is needed as SLN has halved in price since the last annual report. They bought £4M of SLN at 200p, then 300K at 240p. PHC is down 20%. GVC is also down. I think more than a £2M loss will be seen in the P+L unfortunately. I guess they may need to do more buybacks this years otherwise the NAV per share will be way down as well. GVC will go back to 450p once the overhang of people who do not like the merger/dividend holiday go. The same thing happened at Optimal payments. Once the merger is completed, it will lead to a improvement in price as will the move to the main market. How low (1.5p) are the BOD going to let Sarossa go before they do something. The original Sarossa cornerstone investors are way down. They need to bring in another cornerstone investor to hover up the overhang in shares otherwise this will continue down. In Adams plc, cornerston investors own 89.6%. I think they should have the same arrangement. | johnsmith321 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions